European Archives - Page 737 of 1139 - European Medical Journal

An interview with Daniel Carucci, McCann Health

We recently met with Daniel Carucci, Global Medical Director, McCann Health, at the 2019 Cannes Lions Festival of Creativity. Daniel discusses…

Vaccination use Increases Gout Flare Risk

Gout is caused by sodium urate crystals formation in joints, resulting in sudden and severe joint pain. Research had shown that the inflammatory response…

Reduced Coronary Inflammation via Psoriasis Therapy

Associated with heightened systemic inflammation, which elevates the risk of blood vessel disease and diabetes, psoriasis a chronic autoimmune disease…

EMJ Neurology 7.1 2019

This year, the European Academy of Neurology (EAN) annual meeting was held in the cultural and captivating city of Oslo, Norway. There was a huge…

The European Medical Journal Presents: EMJ Neurology 2019

The newest edition of EMJ Neurology is published today, featuring an independent review of this year’s EAN Congress including abstract reviews…

Review of the European Academy of Neurology Congress 2019

Attracting over 6,000 neurologists from countries worldwide, the European Academy of Neurology (EAN) 2019 Congress was a hive for the sharing of…

Optimism and Opportunities with Anti-CGRP Biologics in Migraine: Where Are We Today?

Migraine is a complex neurological disorder with an approximate global prevalence of 15%. It is characterised by a moderate-to-severe unilateral…

Nuclear Factor Erythroid 2-Related Factor 2 as a Gene Modulator of Response to Oxidative Stress in Amyotrophic Lateral Sclerosis

Among the pathogenic mechanisms on motor neuron degeneration leading to amyotrophic lateral sclerosis (ALS), the oxidative stress (OS) theory has been put forward…

Paediatric Migraine: A Multidimensional Disorder

Paediatric migraine is a common medical problem with consecutive impairment in psychosocial development…

Neuroinflammation and its Influence on ‘Non-Inflammatory’ Neurological Diseases

Arguably, the development of treatments for neurological diseases is one the most challenging fields in life sciences.